Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol versus variceal band ligation for primary prevention of variceal bleeding in liver cirrhosis
ISRCTN73887615Phase 3Completed
- Sponsor
- University of Birmingham
- Start
- Jan 2019
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of carvedilol in Cirrhosis and esophageal varices, sponsored by University of Birmingham. Primary endpoint: Any variceal bleeding within 12 months. Started Jan 2019; status: completed.
02
Drugs
carvedilol
03
Conditions
Cirrhosisesophageal varices
Beyond the preview
Go deeper on ISRCTN73887615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN73887615.